Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Sonoma Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. Sonoma Pharmaceuticals shares (SNOA) are listed on the NASDAQ and all prices are listed in US Dollars. Sonoma Pharmaceuticals employs 14 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$5.73|
|52-week range||$5.15 - $10.09|
|50-day moving average||$5.61|
|200-day moving average||$6.80|
|Wall St. target price||$9.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.57|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-20)||-1.55%|
|1 month (2021-09-23)||5.72%|
|3 months (2021-07-27)||-6.83%|
|6 months (2021-04-27)||-27.74%|
|1 year (2020-10-26)||-26.06%|
|2 years (2019-10-25)||13.24%|
|3 years (2018-10-26)||369.67%|
|5 years (2016-10-26)||40.40%|
|Revenue TTM||$16.5 million|
|Gross profit TTM||$6.6 million|
|Return on assets TTM||-14.32%|
|Return on equity TTM||-65.47%|
|Market capitalisation||$15 million|
TTM: trailing 12 months
There are currently 816,842 Sonoma Pharmaceuticals shares held short by investors – that's known as Sonoma Pharmaceuticals's "short interest". This figure is 830.4% up from 87,796 last month.
There are a few different ways that this level of interest in shorting Sonoma Pharmaceuticals shares can be evaluated.
Sonoma Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Sonoma Pharmaceuticals shares currently shorted divided by the average quantity of Sonoma Pharmaceuticals shares traded daily (recently around 2.1 million). Sonoma Pharmaceuticals's SIR currently stands at 0.39. In other words for every 100,000 Sonoma Pharmaceuticals shares traded daily on the market, roughly 390 shares are currently held short.
However Sonoma Pharmaceuticals's short interest can also be evaluated against the total number of Sonoma Pharmaceuticals shares, or, against the total number of tradable Sonoma Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sonoma Pharmaceuticals's short interest could be expressed as 0.3% of the outstanding shares (for every 100,000 Sonoma Pharmaceuticals shares in existence, roughly 300 shares are currently held short) or 0.305% of the tradable shares (for every 100,000 tradable Sonoma Pharmaceuticals shares, roughly 305 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Sonoma Pharmaceuticals.
Find out more about how you can short Sonoma Pharmaceuticals stock.
We're not expecting Sonoma Pharmaceuticals to pay a dividend over the next 12 months.
Sonoma Pharmaceuticals's shares were split on a 1:9 basis on 19 June 2019. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sonoma Pharmaceuticals shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Sonoma Pharmaceuticals shares which in turn could have impacted Sonoma Pharmaceuticals's share price.
Over the last 12 months, Sonoma Pharmaceuticals's shares have ranged in value from as little as $5.15 up to $10.09. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sonoma Pharmaceuticals's is 0.8026. This would suggest that Sonoma Pharmaceuticals's shares are less volatile than average (for this exchange).
Sonoma Pharmaceuticals, Inc. , develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a product indicated to promote healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, pain, and distraction associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a line of products to stimulate expedited healing by targeting various pathogens, as well as antibiotic-resistant strains that slow natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; Lasercyn gel intended for the management of minor skin irritations; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Gramaderm for the treatment of topical mild to moderate acne; Microsafe, a surface disinfectant; and Sinudox for nasal irrigation, including moistening of cuts, abrasions, and lacerations located in the nasal cavity. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.